With the iRGD peptide (targeting neuropilin-1 expressed on pancreatic cancer cells), MRI can detect neuropeptide-1 positive cells expressed on pancreatic cancer cells as well as significantly-enhanced signal of pancreatic cancer. Here, NRP1 is linked to pancreatic neoplasm.